Comparison of dimethyl fumarate and interferon outcomes in an MS cohort

Background To compare the effectiveness of dimethyl fumarate (DMF) with subcutaneous interferon beta-1a (IFNβ-1a) in controlling disease activity in patients with relapsing–remitting Multiple Sclerosis (MS). Methods Clinical and imaging data from patients treated with either IFNβ-1a or DMF for at le...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	BMC neurology Ročník 22; číslo 1; s. 1 - 8
Hlavní autori:	Sattarnezhad, Neda, Healy, Brian C., Baharnoori, Moogeh, Diaz-Cruz, Camilo, Stankiewicz, James, Weiner, Howard L., Chitnis, Tanuja
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London BioMed Central 11.07.2022 BioMed Central Ltd Springer Nature B.V BMC
Predmet:	Clinical trials Cohort Comparative analysis Demographics Demography Dimethyl fumarate Disease activity Drug therapy Effectiveness Gadolinium Interferon Medicine Medicine & Public Health Multiple sclerosis Neurochemistry Neurology Neurosurgery Patient outcomes Patients β-Interferon United States Multiple sclerosis Interferon Disease activity Effectiveness Cohort Dimethyl fumarate
ISSN:	1471-2377, 1471-2377
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!